Chemoinformaics analysis of ALPHA-HYDROXY-LINOLENIC-ACID
| Molecular Weight | 213.233 | nRot | 4 |
| Heavy Atom Molecular Weight | 198.113 | nRig | 8 |
| Exact Molecular Weight | 213.1 | nRing | 1 |
| Solubility: LogS | -2.11 | nHRing | 1 |
| Solubility: LogP | -1.098 | No. of Aliphatic Rings | 1 |
| Acid Count | 2 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 15 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 31.0099 |
| nHD | 3 | BPOL | 17.3541 |
| QED | 0.593 |
| Synth | 4.009 |
| Natural Product Likeliness | 1.223 |
| NR-PPAR-gamma | 0.014 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.006 |
| HIA | 0.348 |
| CACO-2 | -6.173 |
| MDCK | 0.000149431 |
| BBB | 0.321 |
| PPB | 0.227099 |
| VDSS | 0.407 |
| FU | 0.6394 |
| CYP1A2-inh | 0.012 |
| CYP1A2-sub | 0.043 |
| CYP2c19-inh | 0.029 |
| CYP2c19-sub | 0.053 |
| CYP2c9-inh | 0.004 |
| CYP2c9-sub | 0.89 |
| CYP2d6-inh | 0.071 |
| CYP2d6-sub | 0.138 |
| CYP3a4-inh | 0.013 |
| CYP3a4-sub | 0.019 |
| CL | 5.999 |
| T12 | 0.685 |
| hERG | 0.007 |
| Ames | 0.003 |
| ROA | 0.33 |
| SkinSen | 0.342 |
| Carcinogencity | 0.4 |
| EI | 0.054 |
| Respiratory | 0.447 |
| NR-Aromatase | 0.003 |
| Antiviral | No |
| Prediction | 0.917382 |